REGIMAX 120 MG ( ORLISTAT ) TREATMENT OF OBESITY 20 HARD GELATIN CAPSULES

Orlistat Description

Orlistat is an anti-obesity medication used as an adjunct to a reduced-calorie, low-fat diet and regular physical activity for the management of overweight and obesity. It belongs to a class of medications known as gastrointestinal lipase inhibitors and works locally within the gastrointestinal tract to reduce the absorption of dietary fat.

Mechanism of Action

Orlistat exerts its effect by reversibly inhibiting gastric and pancreatic lipases, the enzymes responsible for breaking down dietary triglycerides into absorbable fatty acids and monoglycerides. By inhibiting these enzymes, approximately 30% of dietary fat is prevented from being absorbed and is subsequently eliminated in the feces, resulting in reduced caloric intake and supporting weight loss.

Indications

Orlistat is indicated for:

• Management of obesity in adults with an elevated Body Mass Index (BMI).
• Weight reduction in overweight individuals with obesity-related risk factors such as:
  • Type 2 diabetes mellitus
  • Hypertension
  • Dyslipidemia
  • Cardiovascular risk factors
• Prevention of weight regain following successful weight loss.

Clinical Benefits

When combined with dietary modification and exercise, Orlistat may:

• Promote clinically meaningful weight loss.
• Assist in long-term weight maintenance.
• Improve lipid profiles, including reductions in total and LDL cholesterol.
• Contribute to improved glycemic control in patients with obesity and type 2 diabetes.
• Support reductions in obesity-related cardiovascular risk factors.

Common Adverse Effects

Because Orlistat acts by blocking fat absorption, gastrointestinal side effects are common, particularly when dietary fat intake is high. These may include:

• Oily or fatty stools
• Fecal urgency
• Increased bowel movements
• Flatulence with oily discharge
• Abdominal discomfort
• Fecal incontinence in some cases

Important Warnings

• May reduce the absorption of fat-soluble vitamins (A, D, E, and K); supplementation is often recommended.
• Rare cases of severe liver injury have been reported.
• Contraindicated in patients with chronic malabsorption syndrome or cholestasis.
• Use during pregnancy is not recommended.

Summary

Orlistat is a peripherally acting anti-obesity agent that promotes weight loss by inhibiting gastrointestinal lipases and reducing dietary fat absorption. When used alongside a calorie-controlled, low-fat diet and regular physical activity, it can support weight reduction, improve metabolic parameters, and help maintain long-term weight control in overweight and obese individuals.

Patient Disclaimer: This information is intended for educational purposes only and should not replace professional medical advice. Patients should consult a healthcare professional before starting Orlistat, particularly if they have underlying medical conditions or are taking other medications.

Write a review